2012 Fiscal Year Final Research Report
Development of oxicam-bearing non-steroidal anti-inflammatory drugs with novel anti-parkinsonian mechanism.
Project/Area Number |
22590129
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Medical pharmacy
|
Research Institution | Asahikawa Medical College |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
MATSUBARA Kazuo 旭川医科大学, 医学部, 教授 (20127533)
MATSUBARA Kazuo 京都大学, 医学部, 教授 (20127533)
|
Project Period (FY) |
2010 – 2012
|
Keywords | 臨床薬学 / パーキンソン病進行抑制薬 |
Research Abstract |
In this study, three oxicam-bearing non-steroidal anti-inflammatroy drugs(NSAIDs), such as meloxicam, piroxicam and tenoxicam, were identified to have novel neuroprotective mechanism of maintaining phosphatidylinositol 3-kinase(PI3K)/Akt signaling against MPP^+-induced toxicity using neuroblastoma SH-SY5Y cells. The other types of NSAIDs did not show neuroprotection in the same assays. In a chronic mouse model of Parkinson's disease, meloxicam ameliorated motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling. These results suggest that meloxicam would be a candidate agent as a disease-modifying drug for Parkinson's disease.
|
-
[Journal Article] メロキシカムは,マウスパーキンソン病モデルにおいて,Aktシグナル維持により運動障害とドパミン神経変性を改善する2013
Author(s)
田崎嘉一,山本譲,大村友博,坂口智己,木村周古,大滝康一,小野尚志,須野 学,浅利 優,大久保知子,野田敏宏,粟屋 敏雄,清水惠子,松原和夫.
-
Journal Title
北海道医学雑誌
Volume: 88(1)
Pages: 45
-
[Journal Article] Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model.2012
Author(s)
Tasaki Y, Yamamoto J, Omura T, Sakaguchi T, Kimura N, Ohtaki K, Ono T, Suno M, Asari M, Ohkubo T, Noda T, Awaya T, Shimizu K, Matsubara K.
-
Journal Title
Neurosci Lett
Volume: 521
Pages: 15-19
DOI
-
[Journal Article] Oxicam structure in non-steroidal anti-inflammatory drugs is essential to exhibit Akt-mediated neuroprotection against 1-methyl-4- phenyl, pyridinium-induced cytotoxicity.2012
Author(s)
Tasaki Y, Yamamoto J, Omura T, Noda T, Kamiyama N, Yoshida K, Satomi M, Sakaguchi T, Asari M, Ohkubo T, Shimizu K, Matsubara K.
-
Journal Title
Eur J Pharmacol.
Volume: 676
Pages: 57-63
DOI
-
-
-
[Presentation] Oxicam non-steroidal anti-inflammatory drugs ameliorate motor dysfunction and dopaminergic degeneration by maintaining Akt-signaling in a mouse Parkinson's disease model.2012
Author(s)
Tasaki Y, Yamamoto J, Ohkubo T, Noda T, Omura T, Onoa T., Kimura N., Suno M., T. Sakaguchi, and Matsubara K
Organizer
Neuroscience 2012
Place of Presentation
シカゴ,米国
Year and Date
20121100
-
-
-
[Presentation] Structural specificity of Akt-mediated neuroprotection by oxicam non- steroidal anti-inflammatory drugs against 1-methyl-4-phenyl pyridinium- induced cell death2011
Author(s)
Tasaki Y, Yamamoto J, Omura T, Noda T, Kamiyama N, Yoshida K, Satomi M, Sakaguchi T, Asari T, Ohkubo T, Shimizu K and Matsubara K
Organizer
PDRD
Place of Presentation
上海,中国
Year and Date
20110000